Analyzing Conflicts between Clinical Trials from a Patient Perspective

被引:0
|
作者
MacKellar, Bonnie [1 ]
Schweikert, Christina [1 ]
机构
[1] St Johns Univ, Div Comp Sci Math & Sci, Queens, NY 11439 USA
关键词
clinical trials; eligibility criteria; linked open data; ELIGIBILITY CRITERIA; EXTRACTION;
D O I
暂无
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Patients with serious long-term disease often search for clinical trial information on their own, using sites such as ClinicalTrials.gov. We are developing a patient-focused search tool for clinical trials. Since patients are often concerned that participation in one clinical trial may preclude their participation in other trials, one of the planned features of this system will be the ability to analyze whether treatments in one trial will prevent a patient from participating in another. This paper describes an approach to this task. Eligibility criteria are classified according to linguistic pattern, UMLS concepts, content, and time. The criteria are then compared with treatments and side effects in other trials relevant to a patient, in order to identify potential conflicts.
引用
收藏
页码:479 / 482
页数:4
相关论文
共 50 条
  • [41] Investigator experiences with financial conflicts of interest in clinical trials
    Paula A Rochon
    Melanie Sekeres
    John Hoey
    Joel Lexchin
    Lorraine E Ferris
    David Moher
    Wei Wu
    Sunila R Kalkar
    Marleen Van Laethem
    Andrea Gruneir
    Jennifer Gold
    James Maskalyk
    David L Streiner
    Nathan Taback
    An-Wen Chan
    Trials, 12
  • [42] Analyzing acute procedural pain in clinical trials
    Lang, Elvira V.
    Tan, Gabriel
    Amihai, Ido
    Jensen, Mark P.
    PAIN, 2014, 155 (07) : 1365 - 1373
  • [43] ANALYZING TOXICITY IN CHEMOTHERAPY CLINICAL-TRIALS
    WELLS, HB
    ESPELAND, MA
    MORGAN, TM
    CONTROLLED CLINICAL TRIALS, 1987, 8 (03): : 290 - 290
  • [44] Investigator experiences with financial conflicts of interest in clinical trials
    Rochon, Paula A.
    Sekeres, Melanie
    Hoey, John
    Lexchin, Joel
    Ferris, Lorraine E.
    Moher, David
    Wu, Wei
    Kalkar, Sunila R.
    Van Laethem, Marleen
    Gruneir, Andrea
    Gold, Jennifer
    Maskalyk, James
    Streiner, David L.
    Taback, Nathan
    Chan, An-Wen
    TRIALS, 2011, 12
  • [45] Financial conflicts get more scrutiny in clinical trials
    Agnew, B
    SCIENCE, 2000, 289 (5483) : 1266 - 1267
  • [46] Clinical trials with rofecoxib:: analysis of the information from the gender perspective
    Pérez, SC
    Cantero, MTR
    Pardo, MA
    MEDICINA CLINICA, 2003, 120 (06): : 207 - 212
  • [47] COMPLEXITY OF CLINICAL TRIALS FROM THE PERSPECTIVE OF INVOLVEMENT OF THE PHARMACY DEPARTMENT
    Lamas Marta, Calvin
    Maria Teresa, Rabunal Alvarez
    Fernandez Fernando, Busto
    Gabriel Elena, Fernandez
    Cortizas Begona, Feal
    Maria Isabel, Martin Herranz
    ATENCION FARMACEUTICA, 2012, 14 (06): : 416 - 423
  • [48] A complexity scale for clinical trials from the perspective of a pharmacy service
    Calvin-Lamas, Marta
    Pita-Fernandez, Salvador
    Pertega-Diaz, Sonia
    Rabunal-Alvarez, Maria Teresa
    Martin-Herranz, Isabel
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2018, 25 (05) : 251 - 256
  • [49] CLINICAL RESTENOSIS TRIALS - A PERSPECTIVE FROM THE PHARMACEUTICAL-INDUSTRY
    UPRICHARD, ACG
    TEXTER, M
    CANTER, D
    CIRCULATION, 1992, 85 (04) : 1636 - 1636
  • [50] Augmentation during dopaminergic therapy:: the perspective from clinical trials
    Hoegl, B.
    JOURNAL OF SLEEP RESEARCH, 2006, 15 : 30 - 30